Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study now lists 130 locations and has removed Istanbul, Türkiye. A link to the Genetic and Rare Diseases Information Center is added, and the term B-cell chronic lymphocytic leukemia is included.
    Difference
    0.3%
    Check dated 2026-04-02T05:46:04.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 as part of the page's revision history.
    Difference
    0.0%
    Check dated 2026-03-18T20:48:50.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:48:22.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A minor site version update is shown (Revision: v3.4.2) and the funding-status notice has been removed as part of routine maintenance. These changes do not affect the study content or its presentation, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T10:24:13.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added a site-wide notice about the lapse in government funding and the NIH open status, plus a version update to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T10:13:42.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added a Show glossary option and new QC-related metadata (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0). Removed or deprecated older QC fields (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated)), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T04:50:42.000Z thumbnail image

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.